Skip to main content
The driveway to the Kay Jewelers Pavilion on our Akron Campus will be closed for 2-4 weeks beginning Oct. 10. Click HERE for details.
Go to homepage

Pregabalin for Children 1 mo to 16 years with seizures

Safety and Efficacy of Pregabalin in Children Aged 1 mo to 16 years with Seizures

Description:

For complete information, please view the study on clinicaltrials.gov

Interested in participating?
We are currently recruiting
Full IRB Study Title:
A 12-month Open-label Study To Evaluate The Safety And Tolerability Of Pregabalin As Adjunctive Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-clonic Seizures
IRB Study ID:
111109
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Michael Kohrman, MD

Director, Pediatric Neurology; Co-director, Tuberous Sclerosis Program; Pediatric Neurologist
Pediatric Epilepsy ProgramPediatric NeurologyTuberous Sclerosis ClinicNeuroDevelopmental Science CenterPediatric Sleep Center